The standardized mortality rate for malignant neoplasms in the US is expected to decrease progressively from 167.8 deaths per hundred thousand persons in 2024 to 154.0 in 2028. This represents a year-on-year decrease of approximately 2-2.5%. Over this five-year forecast period, the compound annual growth rate (CAGR) indicates an average annual decrease of about 2.1% in mortality rates.

Future trends to watch for include:

Advancements in healthcare technology and treatment methods could accelerate the decline in mortality rates.
Changes in public health policies and cancer prevention programs may significantly impact these forecasts.
Demographic shifts such as aging population might affect future mortality trends.